drugset / Trial / NCT05944757
Compare of PRP Autologous Serum and Autologous Serum by Intrastromal Injection in Different Eye Disease Conditions
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Platelet-rich plasma (PRP) is an autologous blood product rich in proteins and growth factors. Its application has been the subject of many studies in the field of ophthalmology to stimulate tissue healing and regeneration. Due to its anatomical features (lack of blood vessels), the cornea is among the most susceptible to damage structures of the eye. Therefore, the study of the impact of various regenerative therapies (autologous blood products, serums, ) on corneal lesions is important not only scientifically, but also practically for ophthalmologist. Numerous reports described the healing effect of PRP on corneal lesions.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2023-09-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Autologous serum | Unknown | 0.5 ml | Other |
| Subject | PRP plasma rich platelets | Unknown | 0.5 ml | Other |
Indications
No indication recorded.